Get started
Author

Sadik H. Kassim

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
2018 · Joseph A. Fraietta, Simon F. Lacey, et al. · Nature Medicine · 1,835
Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
2014 · James N. Kochenderfer, Mark E. Dudley, et al. · Journal of Clinical Oncology · 1,622
PDF
A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
2014 · Paul F. Robbins, Sadik H. Kassim, et al. · Clinical Cancer Research · 835
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation
2013 · James N. Kochenderfer, Mark E. Dudley, et al. · Blood · 595
Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2015 · Ling Zhang, Richard A. Morgan, et al. · Clinical Cancer Research · 452
Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease
2025 · Kiran Musunuru, Sarah A. Grandinette, et al. · New England Journal of Medicine · 440
Single-cell multiplexed cytokine profiling of CD19 CAR-T cells reveals a diverse landscape of polyfunctional antigen-specific response
2017 · Qiong Xue, Emily Bettini, et al. · Journal for ImmunoTherapy of Cancer · 132
PDF
In Vivo Ablation of CD11c-Positive Dendritic Cells Increases Susceptibility to Herpes Simplex Virus Type 1 Infection and Diminishes NK and T-Cell Responses
2006 · Sadik H. Kassim, Naveen K. Rajasagi, et al. · Journal of Virology · 127
Characterization of age-related changes in natural killer cells during primary influenza infection in mice
2008 · Shoko Nogusa, Barry W. Ritz, et al. · Mechanisms of Ageing and Development · 112
Gene Therapy in a Humanized Mouse Model of Familial Hypercholesterolemia Leads to Marked Regression of Atherosclerosis
2010 · Sadik H. Kassim, Hui Li, et al. · PLoS ONE · 81
PDF
Adeno-Associated Virus Serotype 8 Gene Therapy Leads to Significant Lowering of Plasma Cholesterol Levels in Humanized Mouse Models of Homozygous and Heterozygous Familial Hypercholesterolemia
2012 · Sadik H. Kassim, Hui Li, et al. · Human Gene Therapy · 72
CD4+T Cells Are Required for the Priming of CD8+T Cells following Infection with Herpes Simplex Virus Type 1
2009 · Naveen K. Rajasagi, Sadik H. Kassim, et al. · Journal of Virology · 52
Biodistribution of AAV8 Vectors Expressing Human Low-Density Lipoprotein Receptor in a Mouse Model of Homozygous Familial Hypercholesterolemia
2013 · Shu-Jen Chen, Julio Sanmiguel, et al. · Human Gene Therapy Clinical Development · 43
Dendritic Cells Are Required for Optimal Activation of Natural Killer Functions following Primary Infection with Herpes Simplex Virus Type 1
2009 · Sadik H. Kassim, Naveen K. Rajasagi, et al. · Journal of Virology · 37
Author Correction: Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
2021 · Joseph A. Fraietta, Simon F. Lacey, et al. · Nature Medicine · 29
PDF
The Bespoke Gene Therapy Consortium: facilitating development of AAV gene therapies for rare diseases
2024 · P. J. Brooks, Timothy M. Miller, et al. · Nature Reviews Drug Discovery · 24
Gene therapy for dyslipidemia: a review of gene replacement and gene inhibition strategies
2010 · Sadik H Kassim, James M Wilson, et al. · Clinical Lipidology · 19
Toward an integrated model of product characterization for CAR-T cell therapy drug development efforts
2017 · Sadik Kassim · Cell and Gene Therapy Insights · 13
The Role of Religion in the Generation of Suicide Bombers
2008 · Sadik H. Kassim · Brief Treatment and Crisis Intervention · 13
Platform solutions for commercial challenges to expanding patient access and making gene editing sustainable
2025 · Sadik H. Kassim, Fyodor Urnov, et al. · Nature Biotechnology · 10
Donor-Derived Anti-CD19 Chimeric-Antigen-Receptor-Expressing T Cells Cause Regression Of Malignancy Persisting After Allogeneic Hematopoietic Stem Cell Transplantation
2013 · James N Kochenderfer, Mark E. Dudley, et al. · Blood · 10
Advancing gene-editing platforms to improve the viability of rare-disease therapeutics: key insights from a 2024 Scientific Exchange hosted by ARM, ISCT, and Danaher
2025 · Fyodor Urnov, Sadik Kassim, et al. · Cytotherapy · 9
Effective Treatment Of Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma With Autologous T Cells Genetically-Engineered To Express An Anti-CD19 Chimeric Antigen Receptor
2013 · James N. Kochenderfer, Mark E. Dudley, et al. · Blood · 9
Systematic identification of novel SLE related autoantibodies responsible for type I IFN production in human plasmacytoid dendritic cells
2013 · Sadik H. Kassim, Jarrat Jordan, et al. · Cellular Immunology · 9
From Lipoproteins to Chondrocytes: A Brief Summary of the European Medicines Agency's Regulatory Guidelines for Advanced Therapy Medicinal Products
2013 · Sadik H. Kassim, Robert P.T. Somerville · Human Gene Therapy · 8
Works count: 59
Citation count: 6,617
H-index: 17
I10-index: 21
Year
Topic
Type